Hicope 25 Tablet contains Hydroxyzine 25mg, an antihistamine with anxiolytic, sedative, and antiemetic properties. It is primarily indicated for the management of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. Hydroxyzine acts by competitively inhibiting the H1 histamine receptors, thereby reducing the effects of histamine in the body. Additionally, it exhibits anticholinergic and sedative effects, which contribute to its efficacy in alleviating pruritus caused by allergic conditions such as chronic urticaria and atopic dermatitis. Hicope 25 is also utilized as a premedication to induce sedation and reduce nausea and vomiting during surgical procedures. The recommended dosage should be individualized based on the patient’s condition and response to therapy, with careful consideration given to elderly patients and those with hepatic or renal impairment. Common adverse effects include drowsiness, dry mouth, and headache, with rare instances of extrapyramidal symptoms. Caution is advised when co-administered with CNS depressants or alcohol due to potential additive sedative effects. Hicope 25 should be used under medical supervision to ensure safe and effective treatment outcomes.